StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
54
This year
3
Publishing Date
2024 - 02 - 20
1
2024 - 02 - 19
1
2024 - 02 - 12
1
2023 - 12 - 12
2
2023 - 12 - 07
1
2023 - 12 - 06
1
2023 - 12 - 01
2
2023 - 11 - 03
1
2023 - 10 - 27
1
2023 - 10 - 25
1
2023 - 09 - 26
1
2023 - 09 - 18
1
2023 - 08 - 31
1
2023 - 07 - 03
1
2023 - 06 - 12
1
2023 - 04 - 28
2
2023 - 03 - 24
1
2023 - 03 - 16
1
2023 - 03 - 14
1
2023 - 02 - 08
1
2023 - 01 - 18
1
2022 - 12 - 14
1
2022 - 12 - 13
1
2022 - 12 - 08
1
2022 - 11 - 30
1
2022 - 11 - 17
1
2022 - 10 - 04
1
2022 - 09 - 28
1
2022 - 09 - 26
1
2022 - 09 - 23
1
2022 - 09 - 19
2
2022 - 09 - 16
1
2022 - 08 - 08
1
2022 - 08 - 03
1
2022 - 05 - 11
1
2022 - 04 - 29
1
2022 - 04 - 26
1
2022 - 03 - 16
1
2022 - 03 - 14
1
2022 - 03 - 07
1
2022 - 03 - 04
1
2021 - 10 - 22
1
2021 - 10 - 07
1
2021 - 09 - 23
1
2021 - 09 - 22
1
2021 - 07 - 16
1
2021 - 05 - 12
1
2021 - 05 - 10
1
2021 - 04 - 09
1
2021 - 04 - 02
1
Sector
Consumer non-durables
1
Electronic technology
1
Health technology
54
Information
1
Manufacturing
15
N/a
2
Tags
Advantage
1
Alzheimer's
5
Alzheimer’s
2
America
7
Antibody
1
Application
1
Approval
2
Biomarkers
2
Biosimilar
3
Cancer
3
Cell
1
Companies
1
Covid
2
Covid-19
2
Dementia
1
Disease
13
Drug
7
Europe
1
Expansion
1
Expected
1
Eye
1
Favorable
1
Gene therapy
1
Global
9
Growing
4
Growth
23
Health
1
Market
39
Multiple sclerosis
1
Muscular atrophy
1
N/a
53
Nervous system
1
Neurodegenerative
1
Neurological
2
Novartis
2
Order
1
Orphan drug
1
Parkinson's
2
Pipeline
1
Propel
1
Protein
1
Rare
2
Report
6
Research
8
Revenue
1
Risk
1
Roche
1
Sclerosis
2
Set
2
Syndros
1
System
2
T-cell
1
Therapeutics
17
Therapy
11
Treatment
5
Entities
3m company
13
Abbott laboratories
120
Abbvie inc.
239
Abeona therapeutics inc.
7
Adaptimmune therapeutics plc
15
Alcon inc.
15
Alkermes plc
10
Amgen inc.
196
Astellas pharma inc
70
Astrazeneca plc
199
Autolus therapeutics plc
7
Bausch health companies inc.
74
Baxter international inc.
48
Becton, dickinson and company
19
Beigene, ltd.
7
Biogen inc.
54
Biontech se
10
Bluebird bio, inc.
11
Boston scientific corporation
17
Brainstorm cell therapeutics inc.
8
Bristol-myers squibb company
103
Csl ltd
9
Danaher corporation
11
Eli lilly and company
138
Endo international plc
20
General electric company
8
Genmab a/s
21
Gilead sciences, inc.
28
Glaxosmithkline plc
305
Grifols sa
10
Incyte corporation
21
Ionis pharmaceuticals, inc.
9
Jazz pharmaceuticals plc
14
Johnson & johnson
245
Koninklijke philips n.v.
19
Mallinckrodt plc
17
Medtronic plc
36
Morphosys ag
16
Novartis ag
1245
Novo nordisk a/s
28
Orange
8
Orchard therapeutics plc
9
Perrigo company
8
Pfizer, inc.
88
Precision biosciences, inc.
8
Reckitt benckiser group plc
10
Regeneron pharmaceuticals, inc.
13
Regenxbio inc.
12
Sanofi
330
Stryker corporation
12
Takeda pharmaceutical company limited
58
Terumo corp
9
Teva pharmaceutical industries limited
9
Teva pharmaceutical industries ltd
206
Thermo fisher scientific inc
51
Ucb s.a.
8
Uniqure n.v.
12
Vericel corporation
8
Viatris inc.
120
Xencor, inc.
11
Symbols
AAPL
4
ABBV
37
ABEO
7
ABSI
4
ABT
8
ADAP
7
ALKS
5
ALNY
5
ALPMF
11
ALPMY
11
AMGN
49
AMRN
3
ARAV
3
AZN
22
AZNCF
20
BABA
6
BAX
11
BCLI
5
BHC
7
BIIB
381
BLUE
3
BMY
11
CIEN
3
CYDY
4
DNLI
14
DRRX
3
EDIT
3
EMKR
3
GBIO
7
GIFLF
4
GIKLY
4
GILD
6
GLAXF
23
GLPG
4
GLPGF
4
GSK
24
INCY
4
INTC
6
IONS
23
IOVA
4
JAZZ
4
JNJ
29
KMDA
4
LLY
20
LMT
6
MSFT
6
NOK
6
NVIV
4
NVO
7
NVS
54
NVSEF
47
ORTX
8
REGN
4
SAGE
20
SNY
53
SNYNF
48
TAK
6
TEVJF
28
TMO
7
VTRS
15
Exchanges
Nasdaq
54
Nyse
54
Crawled Date
2024 - 02 - 20
1
2024 - 02 - 19
1
2024 - 02 - 12
1
2023 - 12 - 12
2
2023 - 12 - 07
1
2023 - 12 - 06
1
2023 - 12 - 01
2
2023 - 11 - 03
1
2023 - 10 - 27
1
2023 - 10 - 25
1
2023 - 09 - 26
1
2023 - 09 - 18
1
2023 - 08 - 31
1
2023 - 07 - 03
1
2023 - 06 - 12
1
2023 - 04 - 28
2
2023 - 03 - 24
1
2023 - 03 - 16
1
2023 - 03 - 14
1
2023 - 02 - 09
1
2023 - 01 - 18
1
2022 - 12 - 15
1
2022 - 12 - 13
1
2022 - 12 - 09
1
2022 - 11 - 30
1
2022 - 11 - 17
1
2022 - 10 - 04
1
2022 - 09 - 28
1
2022 - 09 - 26
1
2022 - 09 - 23
1
2022 - 09 - 19
2
2022 - 09 - 16
1
2022 - 08 - 08
1
2022 - 08 - 03
1
2022 - 05 - 11
1
2022 - 04 - 29
1
2022 - 04 - 26
1
2022 - 03 - 16
1
2022 - 03 - 14
1
2022 - 03 - 07
1
2022 - 03 - 04
1
2021 - 10 - 22
1
2021 - 10 - 07
1
2021 - 09 - 23
2
2021 - 07 - 16
1
2021 - 05 - 12
1
2021 - 05 - 10
1
2021 - 04 - 09
1
2021 - 04 - 02
1
Crawled Time
00:00
3
01:00
6
02:00
2
03:00
3
04:00
3
06:00
1
07:00
1
08:00
4
09:00
3
10:00
1
11:00
2
12:00
2
12:20
1
15:00
1
15:20
1
15:30
2
16:00
3
17:00
2
18:00
1
19:00
3
20:00
1
21:00
2
22:00
3
23:00
3
Source
www.biospace.com
1
www.prnewswire.com
53
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Biogen inc.
symbols :
NVS
save search
Biosimilar Lymphocyte Modulator Global Market Report 2024 - Robust 10.6% CAGR Forecast, Amid Rising Autoimmune Disease Prevalence
Published:
2024-02-20
(Crawled : 03:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-4.1%
|
O:
2.81%
H:
0.0%
C:
-0.95%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-1.33%
|
O:
2.91%
H:
0.35%
C:
-0.38%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-11.82%
|
O:
-0.69%
H:
1.24%
C:
0.76%
disease
biosimilar
report
global
market
9.18% CAGR growth in Cancer Biologics Market by Product (Monoclonal antibodies, Cell and gene therapy, vaccines, and others), Route Of Administration, and Geography- Global forecast to 2028
Published:
2024-02-19
(Crawled : 16:00)
- prnewswire.com
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
Email alert
Add to watchlist
JAZZ
|
$108.38
-1.18%
-1.19%
400K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
cancer
cell
global
growth
market
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
-4.81%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
16.27%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-12.29%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-6.74%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-1.66%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-4.43%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
0.41%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
0.24%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-1.53%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
-2.04%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
$15.66
3.57%
3.45%
430K
|
Health Technology
|
-16.97%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
$400.66
-1.05%
-1.06%
810K
|
Health Technology
|
-3.25%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
1.86%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.47
4.22%
4.05%
690
|
Health Technology
|
-8.14%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$51.72
0.14%
0.14%
1.5M
|
Health Technology
|
-10.7%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-21.07%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
15.37%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$375.0
-0.02%
-0.02%
200K
|
Health Technology
|
-4.49%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
-7.1%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
Alzheimer's Disease Therapeutics Market size to grow by USD 5.41 billion from 2023-2028; North America to account for 39% of market growth - Technavio
Published:
2023-12-12
(Crawled : 20:00)
- prnewswire.com
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
28.85%
|
O:
-10.21%
H:
0.0%
C:
0.0%
GIKLY
|
$4.4
132.75%
150
|
Manufacturing
|
-38.8%
|
O:
2.92%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
0.7%
|
O:
0.71%
H:
0.88%
C:
0.85%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
10.64%
|
O:
-0.17%
H:
1.17%
C:
0.86%
DNLI
|
$15.55
-3.48%
-3.6%
940K
|
Health Technology
|
-16.49%
|
O:
2.9%
H:
8.82%
C:
8.56%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-22.43%
|
O:
0.09%
H:
2.58%
C:
2.52%
america
disease
alzheimer's
therapeutics
growth
market
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | North America is estimated to contribute 39% to the growth - Technavio
Published:
2023-12-12
(Crawled : 08:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
-20.5%
|
O:
-0.42%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
0.0%
|
O:
1.56%
H:
0.51%
C:
0.51%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-20.12%
|
O:
-5.13%
H:
5.41%
C:
3.46%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
1.62%
|
O:
0.45%
H:
0.75%
C:
0.46%
ORTX
|
$16.7
0.0%
370K
|
Health Technology
|
2.15%
|
O:
0.18%
H:
0.43%
C:
0.25%
GBIO
|
News
|
$2.995
-8.13%
-8.85%
110K
|
Health Technology
|
83.15%
|
O:
5.62%
H:
3.72%
C:
-4.26%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-21.51%
|
O:
0.59%
H:
1.35%
C:
0.6%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
0.51%
|
O:
1.83%
H:
0.04%
C:
-1.13%
ADAP
|
$1.085
-4.83%
-5.07%
780K
|
Health Technology
|
126.87%
|
O:
-0.46%
H:
5.56%
C:
-1.12%
ABEO
|
News
|
$3.165
-7.19%
-7.74%
2.2M
|
Health Technology
|
-26.03%
|
O:
0.65%
H:
2.59%
C:
0.86%
america
therapy
growth
market
Antibody Therapeutics Market Worth $479.0 Billion | MarketsandMarkets
Published:
2023-12-07
(Crawled : 15:30)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
2.32%
|
O:
-1.66%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
1.87%
|
O:
-0.97%
H:
0.3%
C:
-0.19%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-5.6%
|
O:
-1.61%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
16.97%
|
O:
1.97%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
1.71%
|
O:
-1.19%
H:
0.0%
C:
0.0%
REGN
|
News
|
$906.55
-0.09%
-0.08%
370K
|
Health Technology
|
8.56%
|
O:
0.51%
H:
1.22%
C:
1.09%
IMNM
|
$14.28
-2.59%
-2.66%
560K
|
Health Technology
|
86.99%
|
O:
-0.64%
H:
1.67%
C:
-1.16%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-17.4%
|
O:
1.67%
H:
0.91%
C:
0.57%
antibody
therapeutics
market
Parkinson's Disease Therapeutics Market revenue to hit USD 12.32 Billion by 2033, Says We Market Research
Published:
2023-12-06
(Crawled : 15:30)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
10.33%
|
O:
1.64%
H:
0.0%
C:
-1.33%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
1.95%
|
O:
0.52%
H:
0.18%
C:
-0.43%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
13.52%
|
O:
-0.03%
H:
0.28%
C:
-0.41%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
26.79%
|
O:
0.99%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
17.27%
|
O:
0.26%
H:
0.0%
C:
0.0%
DNLI
|
$15.55
-3.48%
-3.6%
940K
|
Health Technology
|
-13.11%
|
O:
0.05%
H:
5.74%
C:
3.18%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-15.85%
|
O:
0.42%
H:
2.37%
C:
1.45%
disease
parkinson's
revenue
research
therapeutics
market
Neuromuscular Disease Therapeutics Market size to grow by USD 65.13 billion from 2022-2027| Aquestive Therapeutics Inc., Bausch Health Companies Inc., Biogen Inc. and more among the major companies in the market- Technavio
Published:
2023-12-01
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
Email alert
Add to watchlist
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
Email alert
Add to watchlist
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
BCLI
A
|
$0.5339
1.7%
1.67%
190K
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
disease
companies
health
therapeutics
market
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | Growing research in gene therapy for CVDs and orphan diseases is the major market trend- Technavio
Published:
2023-12-01
(Crawled : 08:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
-19.29%
|
O:
3.87%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-0.54%
|
O:
1.48%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-21.96%
|
O:
-3.37%
H:
4.51%
C:
4.51%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
0.98%
|
O:
-0.25%
H:
0.68%
C:
0.48%
ORTX
|
$16.7
0.0%
370K
|
Health Technology
|
2.53%
|
O:
-0.09%
H:
0.0%
C:
0.0%
GBIO
|
News
|
$2.995
-8.13%
-8.85%
110K
|
Health Technology
|
188.5%
|
O:
0.0%
H:
38.05%
C:
23.01%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-17.47%
|
O:
-0.06%
H:
0.35%
C:
0.29%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
1.45%
|
O:
0.12%
H:
0.97%
C:
0.92%
ADAP
|
$1.085
-4.83%
-5.07%
780K
|
Health Technology
|
128.0%
|
O:
-5.76%
H:
16.36%
C:
15.07%
ABEO
|
News
|
$3.165
-7.19%
-7.74%
2.2M
|
Health Technology
|
-30.97%
|
O:
-2.43%
H:
0.0%
C:
0.0%
research
growing
therapy
market
Gene Therapy Market size to grow by USD 4.61 billion from 2022 to 2027, North America to account for 39% of market growth- Technavio
Published:
2023-11-03
(Crawled : 23:00)
- prnewswire.com
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
Email alert
Add to watchlist
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
Email alert
Add to watchlist
ORTX
|
$16.7
0.0%
370K
|
Health Technology
|
Email alert
Add to watchlist
ABEO
|
News
|
$3.165
-7.19%
-7.74%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
GBIO
|
News
|
$2.995
-8.13%
-8.85%
110K
|
Health Technology
|
Email alert
Add to watchlist
ADAP
|
$1.085
-4.83%
-5.07%
780K
|
Health Technology
|
Email alert
Add to watchlist
AAPL
|
$168.99
1.25%
1.24%
48M
|
Electronic Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
Email alert
Add to watchlist
america
therapy
market
Technological Advancements and Research Efforts Propel Neuromuscular Disease Therapeutics Market Growth
Published:
2023-10-27
(Crawled : 01:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-10.45%
|
O:
-18.18%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
0.85%
|
O:
-3.68%
H:
0.0%
C:
0.0%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
26.36%
|
O:
0.0%
H:
0.17%
C:
-2.45%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.84%
|
O:
-0.23%
H:
0.08%
C:
-1.92%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
26.75%
|
O:
-0.59%
H:
0.15%
C:
-1.79%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-11.44%
|
O:
-15.73%
H:
0.0%
C:
0.0%
BCLI
A
|
$0.5339
1.7%
1.67%
190K
|
Health Technology
|
229.19%
|
O:
3.73%
H:
1.8%
C:
-4.19%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-19.87%
|
O:
-0.45%
H:
0.12%
C:
-2.28%
propel
disease
research
therapeutics
growth
market
Biosimilars market size to increase by USD 42.22 billion | Market driven by the notable price advantage of biosimilars compared to biologics - Technavio
Published:
2023-10-25
(Crawled : 03:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-8.94%
|
O:
0.4%
H:
1.29%
C:
1.29%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
24.7%
|
O:
-0.44%
H:
0.33%
C:
-1.1%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.16%
|
O:
0.64%
H:
0.46%
C:
-0.09%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
16.8%
|
O:
0.65%
H:
0.54%
C:
-0.58%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-10.17%
|
O:
1.43%
H:
0.64%
C:
-0.09%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-23.37%
|
O:
-0.88%
H:
0.34%
C:
-1.27%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
-0.93%
|
O:
-0.37%
H:
0.58%
C:
-1.07%
advantage
market
Regenerative Medicine Market Size to Hit USD 44.63 Billion by 2024, with at a 20.16% CAGR Over the Forecast Period | Brandessence Market Research
Published:
2023-09-26
(Crawled : 08:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
11.68%
|
O:
-3.05%
H:
1.75%
C:
0.5%
SYK
|
$336.85
0.58%
0.0%
1.5M
|
Health Technology
|
16.54%
|
O:
-0.92%
H:
0.24%
C:
-3.93%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-2.9%
|
O:
-0.07%
H:
0.46%
C:
-0.31%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-17.19%
|
O:
-0.49%
H:
0.65%
C:
-0.56%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
11.08%
|
O:
1.16%
H:
0.13%
C:
-0.32%
VCEL
|
$46.09
-0.71%
-0.72%
200K
|
Health Technology
|
36.53%
|
O:
0.38%
H:
1.7%
C:
-1.85%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-24.25%
|
O:
-0.02%
H:
1.37%
C:
1.21%
research
market
Large Molecule Injectable Drugs Market to grow by USD 191.45 billion from 2022-2027 | North America to account for 45% of market growth - Technavio
Published:
2023-09-18
(Crawled : 09:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
5.62%
|
O:
2.7%
H:
0.0%
C:
-5.11%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
1.46%
|
O:
-2.01%
H:
1.73%
C:
-2.99%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
12.39%
|
O:
-0.05%
H:
0.0%
C:
-1.31%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-3.67%
|
O:
0.06%
H:
0.09%
C:
-0.6%
MDT
|
$80.38
-1.12%
0.0%
5M
|
Health Technology
|
-0.59%
|
O:
0.59%
H:
1.69%
C:
0.67%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
10.18%
|
O:
0.72%
H:
0.13%
C:
-0.93%
BAX
|
$40.93
-0.22%
0.0%
2.2M
|
Health Technology
|
4.96%
|
O:
-0.13%
H:
0.28%
C:
-0.77%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
11.06%
|
O:
0.33%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-14.44%
|
O:
-1.29%
H:
0.0%
C:
0.0%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-24.18%
|
O:
0.06%
H:
0.44%
C:
-0.64%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
3.78%
|
O:
-0.76%
H:
0.16%
C:
-1.65%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
4.92%
|
O:
1.02%
H:
0.7%
C:
-0.09%
america
growth
market
Global Rheumatoid Arthritis Drugs Market 2023: Players Include Abbvie, Roche Holding, Novartis and Johnson & Johnson
Published:
2023-08-31
(Crawled : 23:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
13.26%
|
O:
-3.09%
H:
0.44%
C:
0.44%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-1.61%
|
O:
0.83%
H:
0.06%
C:
-0.58%
K
S
|
$58.75
1.05%
0.0%
2.3M
|
Consumer Non-Durables
|
-5.27%
|
O:
-0.43%
H:
0.54%
C:
-2.0%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-7.43%
|
O:
-0.11%
H:
0.0%
C:
0.0%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
33.35%
|
O:
0.22%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
14.21%
|
O:
-0.35%
H:
0.0%
C:
0.0%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-27.75%
|
O:
0.62%
H:
0.26%
C:
-0.68%
global
novartis
roche
market
Rare Diseases Global Market Report 2023: Revenue Set to Surpass $205 Billion in 2023
Published:
2023-07-03
(Crawled : 17:00)
- prnewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-2.03%
|
O:
-1.21%
H:
0.03%
C:
-0.92%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-9.58%
|
O:
-0.71%
H:
0.03%
C:
-0.6%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-23.39%
|
O:
-0.02%
H:
1.51%
C:
0.77%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
25.84%
|
O:
-0.54%
H:
1.07%
C:
0.75%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-11.98%
|
O:
1.24%
H:
0.0%
C:
0.0%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-32.18%
|
O:
-0.7%
H:
0.98%
C:
0.91%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
23.21%
|
O:
-0.36%
H:
1.97%
C:
1.72%
rare
report
global
set
market
Gene Therapy Market size is set to grow by USD 4,613.9 million from 2022 to 2027; Increase in special drug designations boosts the market growth - Technavio
Published:
2023-06-12
(Crawled : 15:00)
- prnewswire.com
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-41.49%
|
O:
-0.68%
H:
3.23%
C:
1.55%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-2.05%
|
O:
-0.16%
H:
0.11%
C:
-0.76%
ORTX
|
$16.7
0.0%
370K
|
Health Technology
|
241.48%
|
O:
0.62%
H:
4.57%
C:
2.04%
GBIO
|
News
|
$2.995
-8.13%
-8.85%
110K
|
Health Technology
|
-32.64%
|
O:
0.0%
H:
11.57%
C:
6.4%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-37.46%
|
O:
3.52%
H:
0.0%
C:
-1.99%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
25.04%
|
O:
0.22%
H:
0.0%
C:
-0.86%
ADAP
|
$1.085
-4.83%
-5.07%
780K
|
Health Technology
|
15.45%
|
O:
-0.75%
H:
7.14%
C:
6.12%
ABEO
|
News
|
$3.165
-7.19%
-7.74%
2.2M
|
Health Technology
|
-19.76%
|
O:
0.0%
H:
4.4%
C:
3.29%
drug
set
therapy
growth
market
Protein Therapeutics Market size to grow by USD 153.56 billion, the availability of favorable reimbursement policies to drive the market growth - Technavio
Published:
2023-04-28
(Crawled : 01:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-15.36%
|
O:
-1.21%
H:
0.12%
C:
-2.76%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
-3.9%
|
O:
-0.41%
H:
0.79%
C:
0.79%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-3.69%
|
O:
-0.79%
H:
0.89%
C:
0.72%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
13.88%
|
O:
-0.6%
H:
2.31%
C:
2.13%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-15.56%
|
O:
-2.09%
H:
0.0%
C:
0.0%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-34.23%
|
O:
0.06%
H:
3.94%
C:
3.51%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
-3.97%
|
O:
-1.03%
H:
1.02%
C:
0.28%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
13.81%
|
O:
-1.46%
H:
1.39%
C:
1.23%
favorable
protein
therapeutics
growth
market
Global Rare Neurological Disease Treatment Market Report 2023: Promising Pipeline Drugs for Treatment of Rare Neurological Diseases Drives Growth
Published:
2023-04-28
(Crawled : 01:00)
- prnewswire.com
CSLLY
|
$90.71
3.3%
35K
|
n/a
|
-10.06%
|
O:
-1.61%
H:
0.55%
C:
0.52%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-3.69%
|
O:
-0.79%
H:
0.89%
C:
0.72%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-34.23%
|
O:
0.06%
H:
3.94%
C:
3.51%
rare
disease
report
pipeline
treatment
global
neurological
growth
market
Non-hodgkin lymphoma therapeutics market size to increase by USD 5,427.51 million between 2022 and 2027; Growing awareness about cancer as a key trend - Technavio
Published:
2023-03-24
(Crawled : 19:00)
- prnewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
Email alert
Add to watchlist
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
BAX
|
$40.93
-0.22%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
Email alert
Add to watchlist
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
Email alert
Add to watchlist
cancer
growing
therapeutics
market
← Previous
1
2
3
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.